TransMedics Group, Inc. TMDX recently issued a statement refuting the claims made in a report by short-seller Scorpion Capital on Jan. 10, 2025, stating them as inaccurate and misleading. Per the ...

TransMedics (TMDX) Group addressed what we believe are inaccurate and misleading claims made in a short-seller report issued by Scorpion Capital on January 10. In response, the company issued the ...

Last Friday, Scorpion Capital published a 342-page short report -- yes, 342 pages! -- detailing an alleged six-month investigation into TransMedics and its business practices. TransMedics has ...

09:17 EST TransMedics (TMDX) down 10% to $65.39 after Scorpion Capital short report Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline ...

TransMedics' stock price has dropped $9.84, or 13%, since Scorpion released a report, titled "Walk Like An Egyptian," leveling serious allegations against the company, including fraud, organ ...

Scorpion alleged the company operates a "mafia ... a disastrous Dec investor day and 2025 guide – back half weighted, naturally,” report said. Shares of TransMedics fell 13% at $63 before ...

TransMedics has had a tough stretch of late. Last Friday, short-seller Scorpion Capital published a short report on the company. Management vehemently denied wrongdoing, and said it was exploring ...